Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Antihypertensive Drugs: Action of Diuretics

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...

Antihypertensive Drugs: Potassium-Sparing Diuretics

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...

Antihypertensive Drugs: Angiotensin II Receptor Blockers

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Juvenile nasopharyngeal angiofibroma: nationwide study on incidence, diagnosis, treatment, and recurrence.

Rhinology·2026

Same author

New implantable cardiac monitor with three-lead ECG and active noise detection.

Herz·2016

Same author

[Incidental finding: elevated TSH level].

Der Internist·2014

Same author

[Mediterranean diet for primary prevention of cardiovascular diseases : Prevención-con-Dieta-Mediterránea (PREDIMED) Study].

Der Internist·2014

Same author

Caloric restriction increases serum testosterone concentrations in obese male subjects by two distinct mechanisms.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2013

Same author

Neuronal overexpression of insulin receptor substrate 2 leads to increased fat mass, insulin resistance, and glucose intolerance during aging.

Age (Dordrecht, Netherlands)·2012

Search research articles

Related Experiment Video

Updated: Jan 13, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

Metabolic changes during antihypertensive therapies.

W Krone¹, H Nägele

¹Medizinische Kernklinik und Poliklinik, Universitäts-Krankenhaus Eppendorf, Hamburg, West Germany.

Journal of Human Hypertension

|December 1, 1989

Summary

Antihypertensive drugs impact lipid metabolism differently. Alpha-blockers improve lipoprotein profiles, while beta-blockers may worsen them, affecting cardiovascular outcomes.

Area of Science:

Cardiovascular Pharmacology
Lipid Metabolism

Background:

Controversy exists regarding the cardiovascular benefits of antihypertensive drugs in primary prevention.
Adverse effects on lipid metabolism, particularly by adrenergic agents, may explain some study failures.
Beta-blockers can negatively impact triglyceride and high-density lipoprotein (HDL) cholesterol levels.

Purpose of the Study:

To review the effects of adrenergic antihypertensives on plasma lipid and lipoprotein levels.
To explore potential mechanisms underlying these effects, including catecholamine regulation of LDL receptors.
To compare the lipid profiles associated with alpha-blockers versus beta-blockers.

Main Methods:

Literature review of studies on antihypertensive drugs and lipid metabolism.

More Related Videos

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

Related Experiment Videos

Last Updated: Jan 13, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

Discussion of laboratory findings on catecholamine regulation of LDL receptor activity.

Analysis of potential impacts on enzymes like lipoprotein lipase.

Main Results:

Beta-blockers tend to increase triglycerides and very low-density lipoprotein (VLDL)-cholesterol, and may decrease HDL-cholesterol.
Alpha 1-adrenergic inhibitors (e.g., prazosin, doxazosin) lower triglycerides, total cholesterol, low-density lipoprotein (LDL)- and VLDL-cholesterol, and increase HDL-cholesterol.
Catecholamines regulate peripheral LDL receptor activity via alpha 2- and beta 2-adrenergic receptors, with antagonists reversing these effects.

Conclusions:

Adrenergic antihypertensives exhibit distinct effects on plasma lipids and lipoproteins.
Alpha-blockers demonstrate a favorable lipid profile compared to beta-blockers.
Further long-term studies are necessary to determine the clinical significance of these metabolic differences.